Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)

Cellebrite DI has reported Cash & Current Investments over the past 5 years, most recently at $285.5 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $285.5 million for Q4 2025, down 17.34% from a year ago — trailing twelve months through Dec 2025 was $285.5 million (down 17.34% YoY), and the annual figure for FY2025 was $285.5 million, down 17.34%.
  • Cash & Current Investments for Q4 2025 was $285.5 million at Cellebrite DI, down from $345.4 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for CLBT hit a ceiling of $345.4 million in Q4 2024 and a floor of $132.3 million in Q4 2022.
  • Median Cash & Current Investments over the past 4 years was $256.9 million (2023), compared with a mean of $247.9 million.
  • Biggest five-year swings in Cash & Current Investments: soared 72.51% in 2023 and later dropped 17.34% in 2025.
  • Cellebrite DI's Cash & Current Investments stood at $132.3 million in 2022, then surged by 72.51% to $228.2 million in 2023, then surged by 51.35% to $345.4 million in 2024, then dropped by 17.34% to $285.5 million in 2025.
  • The last three reported values for Cash & Current Investments were $285.5 million (Q4 2025), $345.4 million (Q4 2024), and $228.2 million (Q4 2023) per Business Quant data.